The anticancer activity of alpha-tomatine against mammary adenocarcinoma in mice

Biomedical Papers

Volumn 157, Issue 2, 2013, Pages 153-161

  Tomsik, Pavel ^a   Micuda, Stanislav ^a   Sucha, Lenka ^a   Cermakova, Eva ^a   Suba, Petr ^a   Zivny, Pavel ^a   Mazurova, Yvona ^b   Knizek, Jiri ^a   Niang, Mohamed ^a   Rezacova, Martina ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Alpha tomatine; Cancer; Doxorubicin; Ehrlich tumour; Survival

Indexed keywords

ALPHA-TOMATINE; ANTINEOPLASTIC ANTIBIOTIC; BILIRUBIN; BIOLOGICAL MARKER; DOXORUBICIN; DRUG DERIVATIVE; TOMATINE;

ANIMAL; ARTICLE; BLOOD; CELL PROLIFERATION; DRUG EFFECT; EHRLICH ASCITES TUMOR; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; LIVER; METABOLISM; MOUSE; WESTERN BLOTTING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BILIRUBIN; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARCINOMA, EHRLICH TUMOR; CELL PROLIFERATION; DOXORUBICIN; FEMALE; LIVER; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; TOMATINE;

MUS;

EID: 84879294103     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2013.031     Document Type: Article

References (45)

1. Friedman M. Tomato glycoalkaloids: Role in the plant and in the diet. J Agric Food Chem 2002;50:5751-80.
2. Schmidt B, Ribnicky DM, Poulev A, Logendra S, Cefalu WT, Raskin I. A natural history of botanical therapeutics. Metabolism 2008;57:S3-9.
3. Friedman M, Fitch TE, Yokoyama WE. Lowering of plasma LDL cholesterol in hamsters by the tomato glycoalkaloid tomatine. Food Chem Toxicol 2000;38:549-53.
4. Thorne HV, Clarke GF, Skuce R. The inactivation of herpes simplex virus by some Solanaceae glycoalkaloids Antiviral Res 1985;5:335-43.
5. Morrow WJW, Yang YW, Sheikh NA. Immunobiology of the tomatine adjuvant. Vaccine 2004;22:2380-4.
6. Friedman M, McQuistan T, Hendricks JD, Pereira C, Bailey GS. Protective effect of dietary tomatine against dibenzo[a,l]pyrene (DBP)-induced liver and stomach tumors in rainbow trout. Mol Nutr Food Res 2007;51:1485-91.
7. Lee KR, Kozukue N, Han JS, Park JH, Chang EY, Baek EJ, Chang JS, Friedman M. Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem 2004;19:2832-9.
8. Friedman M, Levin CE. Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J Agric Food Chem 2009;57:5727-33.
9. Chiu FL, Lin JK. Tomatidine inhibits iNOS and COX-2 through suppression of NF-kappaB and JNK pathways in LPS-stimulated mouse macrophages. FEBS Lett 2008;582:2407-12.
10. Shih YW, Shieh J M, Wu PF, Lee YC, Chen YZ, Chiang TA. α-Tomatine inactivates PI3K/Akt and ERK signaling pathways in human lung adenocarcinoma A549 cells: effect on metastasis. Food Chem Toxicol 2009;47:1985-95.
11. Liao DW, Wang L, Zhang XG, Liu MQ. Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer Chin J Canc 2006; 25:1238-42.
12. Itoh Y, Nagase H. Matrix metalloproteinases in cancer. Essays Biochem 2002;38,21-36.
13. Duffy MJ, Duggan C. The urokinase plasminogen activator system: A rich source of tumor markers for the individualised management of patients with cancer. Clin Biochem 2004;37:541-8.
14. Lee ST, Wong PF, Cheah SC, Mustafa MR Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells. PLoS ONE 2011;6:e18915.
15. Shieh JM, Cheng TH, Shi MD, Wu PF, Chen Y, Ko SC, Shih YW. α-Tomatine suppresses invasion and migration of human non-small cell lung cancer NCI-H460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-κB. Cell Biochem Biophys 2011;60:297-310.
16. Chao MW, Chen CH, Chang YL, Teng CM, Pan SL. α-Tomatine-Mediated Anti-Cancer Activity In Vitro and In Vivo through Cell Cycle-and Caspase-Independent Pathways. PLoS ONE 2012;9:e44093.
17. Kúdelová J, Seifrtová M, Suchá L, Tomšík P, Havelek R, Řezáčová M. Alpha-tomatine activates cell cycle checkpoints in the absence of DNA damage in human leukemic MOLT-4 cells. J Appl Biomed 2013;11:93-103.
18. Nishie K, Norred WP, Swain AP. Pharmacology and toxicology of chaconine and tomatine. Res Commun Chem Pathol Pharmacol 1975;12:657-68.
19. Awara WM, El-Sisi AE, El-Sayad ME, Goda AE. The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of DOX? Pharmacol Res 2004;50:487-98.
20. Klein HO, Toermer HJ, Christian E, Coerper C, Lennartz KJ, Akokan G. Experimental investigations on a sequential combination chemo-therapy protocol. J Cancer Res Clin Oncol 1980;96:65-78.
21. Mattern J, Kaufmann M, Wayss K, Volm M. Studies on the Drug Sensitivity of Short Term Cultivated Tumor Cell Suspensions. In: Dendy, PP,editor. Human Tumors in Short Term Culture, Academic Press, London (UK), New York (NY), San Francisco (CA); 1976. p 301.
22. Tomšík P, Stoklasová A, Mičuda S, Niang M, Šuba P, Knížek J, Řezáčová M. Evaluation of the antineoplastic activity of L-rhamnose in vitro. A comparison with 2-deoxyglucose. Acta Med (Hradec Králové) 2008;51:113-9.
23. Pessina A, Brambilla P, Mocarelli P. Surface antigen on Ehrlich ascites tumor cells. Biomedicine 1980;33:105-9.
24. Segura JA, Barbero LG, Márquez J. Early tumor effect on splenic Th lymphocytes in mice. FEBS Lett 1997;414:1-6.
25. Céspedes MV, Casanova I, Parreño M, Mangues R. Mouse models in oncogenesis and cancer therapy. Clin Transl Oncol 2006;8:318-29.
26. Polin L, Corbett TH, Roberts BJ, Lawson AJ, Leopold III WR, White K, Kushner J, Hazeldine S, Moore R, Rake J, Horwitz JP. Transplantable Syngeneic Rodent Tumors. In: Teicher BA, editor. Tumor Models in Cancer Research, 2nd edn. Humana Press, Springer: New York (NY), Dordrecht (Netherlands), Heidelberg (Germany), London (UK); 2011. p 47
27. Haque E, Baral R. Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 mice by activation of NK cells and NK-T cells. Immunobiology 2006;211:721-31.
28. Israel M, Idriss JM, Koseki Y, Khetarpal VK. Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro. Cancer Chemother Pharmacol 1987;20:277-84.
29. Schaefer A, Boldt J, Westendorf J, Steinheider G, Marquardt H. Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A. Biochem Pharmacol 1988;37: 1377-82.
30. Ebbehoj E, Langkjer ST. Comparison between different parameters of cell viability. In vitro studies in a human cervix cancercell line. J Exp Clin Cancer Res 1995;14:95-101.
31. Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res 2001;21:1189-94.
32. Keukens EA, de Vrije T; van den Boom C, de Waard P, Plasman HH, Thiel F, Chupin V, Jongen WM, de Kruijff B. Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta 1995;1240:216-28.
33. Keukens EA, de Vrije T, Jansen LA, de Boer H, Janssen M, de Kroon AI, Jongen WM, de Kruijff B. Glycoalkaloids selectively permeabilize cholesterol containing biomembranes. Biochim Biophys Acta 1996;1279:243-50.
34. Walker BW, Manhanke N, Stine KJ. Comparison of the interaction of tomatine with mixed monolayers containing phospholipid, egg sphingomyelin, and sterols. Biochim Biophys Acta 2008;1778:2244-57.
35. Hartveit F. The growth of Ehrlich's ascites carcinoma in C3H mice and in mice of an unrelated closed colony. Splenomegaly following intraperitoneal transplantation. Br J Cancer 1966;20:825-30.
36. Lala PK, Terrin M, Lind C, Kaizer L. Hemopoietic redistribution in tumor-bearing mice. Exp Hematol 1978;6:283-98.
37. Rivenson A, Schnelle V, Moroson H, Madden R, Herp A. Variable response of spleen to ehrlich's tumor according to the physical form (ascitic or solid) of the tumor. Experientia 1981;37:195-7.
38. Queiroz ML, Valadares MC, Bincoletto C, Dieamant GC. Ehrlich ascites tumor as a tool in the development of compounds with immunomodulatory properties. Immunopharmacol Immunotoxicol 2004;26:511-25.
39. Theologides A, Pegelow CH. Liver weight changes during distant growth of transplanted tumor. Proc Soc Exp Biol Med 1970;134:1104-8.
40. Friedman M, Henika PR, Mackey BE. Feeding of potato, tomato and eggplant alkaloids affects food consumption and body and liver weights in mice. J Nutr 1996;126:989-9.
41. Dalvi RR. Comparative assessment of the effect of solanine administered orally and intraperitoneally on hepatic dysfunction in male rats. Jpn J Vet Sci (Nihon Juigaku Zasshi) 1985;47:657-9.
42. Kathiriya A, Das K, Kumar EP, Mathai KB. Evaluation of antitumor and antioxidant activity of Oxalis Corniculata Linn. against ehrlich ascites carcinoma on mice. Iran J Cancer Prev 2010;3:157-65.
43. Naveena, Bharath BK, Selvasubramanian. Antitumor activity of Aloe vera against Ehrlich ascitis carcinoma (EAC) in Swiss albino mice. Int J Pharm Bio Sci 2011;2:400-9.
44. Wilson RW, Poley GH, de Eds F. Some pharmacologic and toxicologic properties of tomatine and its derivatives. Toxicol Appl Pharmacol 1961;3:39-48.
45. Mimnaugh EG, Trush MA, Ginsburg E. The effects of adriamycin in vitro and in vivo on hepatic microsomal drug-metabolizing enzymes: Role of microsomal lipid peroxidation. Toxicol Appl Pharmacol 1981;61:313-25.